Int Neurourol J.  2017 Mar;21(1):75-79. 10.5213/inj.1732644.322.

Treatment of Stress Urinary Incontinence in Neurological Patients With an Injectable Elastomer Prosthesis: Preliminary Results

Affiliations
  • 1Divison of Urology, Geneva University Hospital, Geneva, Switzerland. Julien.renard@hcuge.ch
  • 2Division of Neuro-Urology, Ospedale Regionale di Bellinzona and Neurocentro della Svizzera Italiana, Lugano, Switzerland.
  • 3Spinal Unit, Division of Neurourology, A. Zanollo Center for Sacral Area Disfunction, Niguarda Hospital, Milan, Italy.

Abstract

Many treatment options for stress urinary incontinence are difficult to apply to neurological patients. Urolastic is a new agent that is primarily indicated for women with mild stress urinary incontinence or men after prostate surgery. In this report, we present a series of 5 cases describing the first use of Urolastic to treat neurological patients. All patients were evaluated with a voiding diary and the use of auxiliary devices as the main indicators of continence. The median operative time was 30.8 minutes, and no complications were observed. Of the 5 patients, 4 reported improved incontinence: 2 switched from diapers to small pads, while the other 2 patients were able to discontinue urinary condom use. The only instance of treatment failure occurred in a patient with a low-compliance bladder. The advantages of this procedure appear to include a soft-cuff effect, reversibility, and minimal invasiveness. However, a future randomized study would be necessary to validate this treatment option.

Keyword

Urinary Incontinence, Stress; Urinary Bladder, Neurogenic; Injectable; Bulking

MeSH Terms

Condoms
Elastomers*
Female
Humans
Male
Operative Time
Prostate
Prostheses and Implants*
Treatment Failure
Urinary Bladder
Urinary Bladder, Neurogenic
Urinary Incontinence*
Urinary Incontinence, Stress
Elastomers
Full Text Links
  • INJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr